Journal of Obesity

Journal of Obesity / 2013 / Article

Clinical Study | Open Access

Volume 2013 |Article ID 269038 |

Abdulbari Bener, Mohammad T. Yousafzai, Sarah Darwish, Abdulla O. A. A. Al-Hamaq, Eman A. Nasralla, Mohammad Abdul-Ghani, "Obesity Index That Better Predict Metabolic Syndrome: Body Mass Index, Waist Circumference, Waist Hip Ratio, or Waist Height Ratio", Journal of Obesity, vol. 2013, Article ID 269038, 9 pages, 2013.

Obesity Index That Better Predict Metabolic Syndrome: Body Mass Index, Waist Circumference, Waist Hip Ratio, or Waist Height Ratio

Academic Editor: Jordi Salas-Salvadó
Received15 Mar 2013
Revised16 Jul 2013
Accepted16 Jul 2013
Published13 Aug 2013


Aim. The aim was to compare body mass index (BMI), waist circumference (WC), waist hip ratio (WHR), and waist height ratio (WHtR) to identify the best predictor of metabolic syndrome (MetS) among Qatari adult population. Methods. A cross-sectional survey from April 2011 to December 2012. Data was collected from 1552 participants followed by blood sampling. MetS was defined according to Third Adult Treatment Panel (ATPIII) and International Diabetes Federation (IDF). Receiver operating characteristics (ROC) curve analysis was performed. Results. Among men, WC followed by WHR and WHtR yielded the highest area under the curve (AUC) (0.78; 95% CI 0.74–0.82 and 0.75; 95% CI 0.71–0.79, resp.). Among women, WC followed by WHtR yielded the highest AUC (0.81; 95% CI 0.78–0.85 & 0.79; 95% CI 0.76–0.83, resp.). Among men, WC at a cut-off 99.5 cm resulted in the highest Youden index with sensitivity 81.6% and 63.9% specificity. Among women, WC at a cut-off 91 cm resulted in the highest Youden index with the corresponding sensitivity and specificity of 86.5% and 64.7%, respectively. BMI had the lowest sensitivity and specificity in both genders. Conclusion. WC at cut-off 99.5 cm in men and 91 cm in women was the best predictor of MetS in Qatar.

1. Introduction

Metabolic syndrome (MetS) is known to be a cluster of interrelated risk factors of metabolic origin such as elevated blood pressures, glucose metabolism disturbances, dyslipidemia, and obesity [1], which are linked to the development of atherosclerotic cardiovascular diseases and type 2 diabetes mellitus (T2DM) [14]. Out of all these risk factors, obesity or body fat seems to be the predominant underlying risk factor not only in the development of MetS but also other cardiovascular risk factors [5, 6].

It has been widely considered that central obesity as a marker of body fat can be conveniently and cost effectively estimated by measuring body mass index (BMI) and waist circumference (WC) that in turn might effectively predict the risk of MetS [7, 8]. Recently some other indices of abdominal obesity such as waist hip ratio (WHR) and waist height ratio (WHtR) have also been reported to be better discriminators of cardiovascular and metabolic risk factors than BMI and/or WC. However, studies from different countries and ethnicities have different conclusions regarding the superiority of one or the other obesity index and related cut-off points to diagnose obesity and hence MetS [911]. Researchers believe that ethnic and racial variation among population from different regions might need different cut-off points and/or use of different anthropometric measurement to diagnose obesity and MetS [10, 11]. To the best of our knowledge no previous studies in Qatar or neighboring Arab countries have investigated the best indicator for central obesity and related locally appropriate cut-off point for the prediction and diagnosis of MetS among Arab population. Therefore, we conducted this study with the aim to evaluate different obesity indices (BMI, WC, WHR, and WHtR) to identify the one that better predicts metabolic syndrome (MetS) and its related sex-specific optimal cut-off points among Qatari population.

2. Subjects and Methods

We conducted a cross-sectional study among the adult Qatari population above 20 years of age over a period from April 2011 to December 2012. The study protocol was approved by the Ethics committee of Hamad Medical Corporation. Each participant was provided with brief information about the study and was assured of strict confidentiality. Only participants who agreed to participate and gave written consent were included in the study.

2.1. Sampling Procedure

We developed a multistage stratified cluster sampling design using the administrative divisions of the primary health centres (PHC) in Qatar that had approximately equal population coverage. In order to secure a representative sample of the study population, sampling was stratified with a view to obtain proportional representation from urban and semiurban areas. The sample size was determined based on a priori assumption for the prevalence of MetS in Qatar and Eastern Mediterranean region to be 17–20%; with the 99% confidence interval and 2% bound on error of estimation, a minimum sample size of 2,182 would be required for this study. Out of total 22 PHCs available, 13 were selected at random. Of these 10 were located in urban and 3 in semiurban areas of Qatar. Lastly, subjects were selected systematically 1-in-2 sampling procedure. During the study period, 2,182 subjects were approached, of whom 1,552 (71%) consented to participate.

2.2. Questionnaire

We used a well designed and pilot tested questionnaire to collect the data. The questionnaire was tested among 100 subjects as a pilot study before the initiation of the main survey. We made necessary corrections and modifications in the questionnaire based on the findings from the pilot study. The first part of the questionnaire included information about sociodemographic and anthropometric characteristics including age, sex, marital status, education level, occupation, height, weight, and waist and hip circumference. The second part consisted of life style habits such as physical activity, fast food consumption and smoking habits. Last part of the questionnaire comprised of information about systolic and diastolic blood pressures, serum triglyceride, total cholesterol, high-density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, Hemoglobin A1c (HbA1c), and fasting plasma glucose levels (FPG).

2.3. Diagnostic Criteria

We used two different international criteria as given below to diagnose MetS among the participants.(1) National Cholesterol Education Program: Third Adult Treatment Panel (ATP III) [1].According to ATPIII, presence of at least three of these risk factors diagnose the MetS: (a) FPG ≥ 100 mg/dL (5.6 mmol/L); (b) blood Pressure ≥ 130/85 mmHg; (c) triglyceride ≥ 150 mg/dL (1.7 mmol/L); (d) HDL Cholesterol: Men < 40 mg/dL (1.03 mmol/L); women < 50 mg/dL (1.29 mmol/L); (e) men with waist circumference >102 cm and women with waist circumference >88 cm.(2) International Diabetes Federation (IDF) [12].According to IDF, a participant has the MetS if she/he has a waist circumference (≥94 cm in men and ≥80 cm in women) plus any two of these risk factors: (a) FPG ≥ 100 mg/dL (5.6 mmol/L) or previously diagnosed impaired fasting glucose (b) blood pressure ≥ 130/85 mmHg or treatment for hypertension; (c) Triglyceride ≥ 150 mg/dL (1.7 mmol/L); (d) HDL Cholesterol: Men < 40 mg/dL (1.03 mmol/L); Women < 50 mg/dL (1.29 mmol/L) or treatment for low HDL.

2.4. Anthropometric and Blood Pressure Measurements

Physical examination and measurements were performed by a trained nurse. Height was measured in centimetres (cm) using a height scale (SECA, Germany) while the subject was standing bare feet and with normal straight posture. Male subjects were requested to remove their head cover (Igaal and Guttra). Weight was measured in kilograms using a weight scale (SECA, Germany). The subjects were asked to remove any objects from their pockets and to stand on the weight scale bare feet with light clothing. BMI was calculated as the ratio of weight (kilogram) to the square of height (meters). Obesity and overweight were classified according to WHO criteria [13]. A person was considered obese if the BMI value was ≥30 kg/m2, overweight if BMI ≥25 kg/m2 and <30 kg/m2.

Waist circumference was measured in centimetres without compression of the soft tissue at midway level between lower rib margin and iliac crest using nonstretchable measuring tape. The hip circumference was also measured in centimetres using the same measuring tape at its widest portion of the buttocks, with the tape parallel to the floor. Both measurements were taken while the subject was standing with feet closed together, arms at the side, body weight evenly distributed, and wearing little clothing. Also, the measurements were taken at the end of a normal expiration. Waist to Hip ratio (WHR) was calculated by taking the waist circumference (cm) and dividing by the hip circumference (cm) while on the other hand Waist to Height ratio (WHtR) was calculated by taking waist circumference (cm) and dividing by height (cm).

Two readings of the systolic (SBP) and diastolic (DBP) blood pressure were taken from the subject’s left arm while seated and his/her arm at heart level, using a standard zero mercury sphygmomanometer after at least 10–15 minutes of rest. Then the average of the two readings was obtained.

2.5. Laboratory Measurements

A blood sample of 10 mL was collected through venipuncture from each participant after fasting for 10 hours, into vacutainer tubes containing EDTA. The samples were kept at room temperature and transported within 2 hrs to a central certified laboratory at Hamad General Hospital, HMC, Doha, Qatar. Plasma glucose, total cholesterol, triglyceride, HDL-cholesterol, and LDL-cholesterol were measured by an autoanalyser (Hitachi 747 autoanalyzer, Japan).

2.6. Assessment of Lifestyle Factors

Information on cigarette and sheesha smoking was obtained separately by asking questions regarding the smoking status (never smoke, past smoker and current smoker); if smoker then further questions were asked regarding number of years smoked and number of cigarettes smoked per day. Information on physical activity/exercise was also obtained subjectively by asking question regarding any activity causing light perspiration or slight to moderate increase in breathing or heart rate for at least 30 minutes which is performed regularly (yes/no). Information about fast food consumption was measured through a single binary response question “do you eat fast foods? Yes/No.”

2.7. Data Analysis

Data were analyzed using the Statistical Package for Social Sciences version 20 (SPSS Inc., Chicago, IL, USA) software. Continuous variables were tested for normality using histograms and Kolmogorov-Smirnov test. Continuous variables were expressed as mean with standard deviation and categorical variables were expressed as frequency with percentage. Comparison of sociodemographic variables, lifestyle habits, and anthropometric and biochemical measurements between subjects with and without MetS was made using Pearson chi square for categorical variables and independent samples Student’s -test for continuous scale variables. The receiver operating characteristic (ROC) curve was generated to obtain the values of area under the curve (AUC) with 95% CI, and also sensitivity and specificity for each obesity index as a predictor of MetS. To determine the locally appropriate sex-specific cut-off point for each obesity index, the Youden index (sensitivity + specificity − 1) was calculated and the corresponding cut-off value for the highest Youden index was considered as the optimal cut-off value.

In addition, multivariable logistic regression analysis was conducted for total population, males and females separately to identify the strength of association of different obesity indices (adjusting for age, education, smoking status, family history of hypertension and diabetes) and MetS.

3. Results

3.1. Baseline Characteristics

Overall, the prevalence of MetS was 26.2% according to ATPIII and 36.9% according to IDF. Table 1 shows comparison of sociodemographic and lifestyle characteristics between participants with and without MetS in Qatar. Participants with MetS were older, predominantly female and were either retired/not working or housewives as compared to those without MetS using ATPIII criteria ( versus ; , 57% versus 49%; , and 47% versus 39%; , resp.); however, no such difference was observed between the groups based on IDF criteria ( ). Level of education, consumption of fast food, and physical activity were significantly different between groups with and without MetS using both the diagnostic criteria.

Variables  Total
ATPIII valueIDF value
(%) (%) (%) (%) (%)

Age (mean ± SD)42.66 ± 11.145.93 ± 10.0341.50 ± 11.30<0.00142.89 ± 10.7342.52 ± 11.410.534
Age groups (years)
 <35411 (26.5)359 (31.3)52 (12.8)<0.001137 (24.0)274 (28.0)0.239
 35–44.9461 (29.7)333 (29.1)128 (31.5)177 (30.9)284 (29.0)
 45–54.9455 (29.3)314 (27.4)141 (34.7)182 (31.8)273 (27.9)
 55–64.9175 (11.3)102 (8.9)73 (18.0)59 (10.3)116 (11.8)
 65 and above50 (3.2)38 (3.3)12 (3.0)17 (3.0)33 (3.4)
Male gender758 (48.8)174 (42.9)584 (51.0)0.005274 (47.9)484 (49.4)0.572
Education level
 <Secondary863 (55.6)259 (63.8)604 (52.7)<0.001358 (62.6)505 (51.5)0.001
 ≥Secondary689 (44.4)147 (36.2)542 (47.3)214 (37.4)475 (48.5)
 Retired/not working/HW*643 (41.4)191 (47.0)452 (39.4)0.024241 (42.1)402 (41.0)0.911
 Professional756 (48.7)176 (43.3)580 (50.6)275 (48.1)481 (49.1)
 Manual worker153 (9.9)39 (9.6)114 (9.9)56 (9.8)97 (9.9)
Type of residence
 Shabia517 (33.1)121 (29.8)396 (34.6)0.130178 (31.1)339 (34.6)0.346
 Villa909 (58.8)255 (62.8)654 (57.1)344 (60.1)565 (57.7)
 Apartment126 (8.1)30 (7.4)96 (8.4)50 (8.7)76 (7.8)
Marital status
 Married934 (60.2)241 (59.4)693 (60.5)0.694360 (62.9)574 (58.6)0.090
 Single618 (39.8)165 (40.6)453 (39.5)212 (37.1)406 (41.4)
Fast food consumption518 (33.4)164 (40.4)354 (30.9)<0.001217 (37.9)301 (30.7)0.004
Physical activity422 (27.2)86 (21.2)336 (29.3)0.002134 (23.4)288 (29.4)0.011
Smoking status
 Never smoke1246 (80.3)332 (81.8)914 (79.8)0.337459 (80.2)787 (80.3)0.145
 Past smoker147 (9.5)31 (7.6)116 (10.1)46 (8.0)101 (10.3)
 Current smoker159 (10.2)43 (10.6)116 (10.1)67 (11.7)92 (9.4)
Avg. number of years smoked13.25 ± 9.5313.28 ± 11.6013.24 ± 8.860.98412.99 ± 8.7013.71 ± 10.890.624
No. of cigarettes smoke/day (mean ± SD)19.63 ± 13.0122.44 ± 12.7118.81 ± 13.020.09918.93 ± 13.3820.03 ± 12.830.567
Sheesha smoking332 (21.4)83 (20.4)249 (21.7)0.588135 (23.6)197 (20.1)0.105

*HW: housewife.

Almost half of the participants with MetS were obese (BMI ≥ 30) as compared to slightly higher than one third of the metabolically healthy obese individuals (58.6% versus 37.1% using ATPIII criteria and 49.1% versus 39% using IDF criteria; , resp.). Average WC, WHR, WHtR, BMI, FPG, triglycerides, SBP, and DBP were significantly higher among the participants with MetS as compared to those without MetS irrespective of the diagnostic criteria. In contrast, average HDL cholesterol was significantly lower in MetS than without MetS ( versus ; using ATPIII criteria and versus ; using IDF criteria) (Table 2).

Variables Total
= 1,552
ATPIII valueIDF value
(%) (%) (%) (%) (%)

Waist circumference (cm)97.13 ± 12.40106.04 ± 10.1793.97 ± 11.56<0.00198.87 ± 13.2396.11 ± 11.78<0.001
Hip circumference (cm)110.02 ± 9.87113.58 ± 10.27108.75 ± 9.42<0.001110.62 ± 10.85109.67 ± 9.240.068
Height (cm)162.84 ± 9.65162.33 ± 10.03163.02 ± 9.510.215162.84 ± 9.65162.37 ± 9.570.139
Weight (Kg)77.51 ± 15.9783.35 ± 16.9275.44 ± 15.09<0.00178.92 ± 18.1076.69 ± 14.520.008
Waist hip ratio (WHR)0.88 ± 0.090.94 ± 0.080.86 ± 0.08<0.0010.89 ± 0.090.88 ± 0.09<0.001
Waist height ratio0.60 ± 0.080.66 ± 0.070.58 ± 0.08<0.0010.61 ± 0.090.59 ± 0.08<0.001
Body mass index (Kg/m2)29.32 ± 6.1031.87 ± 7.1128.42 ± 5.41<0.00130.10 ± 7.3128.86 ± 5.21<0.001
Body mass index: (%)
 <25377 (24.3)72 (17.7)305 (26.6)<0.001164 (28.7)213 (21.7)<0.001
 25–29.9512 (33.0)96 (23.6)416 (36.3)127 (22.2)385 (39.3)
 ≥30663 (42.7)238 (58.6)425 (37.1)281 (49.1)382 (39.0)
Fasting glucose (mmol/L)6.26 ± 2.548.31 ± 3.435.54 ± 1.62<0.0016.97 ± 3.045.85 ± 1.30<0.001
Haemoglobin A1c (%)6.11 ± 1.597.36 ± 1.935.67 ± 1.18<0.0016.58 ± 1.925.84 ± 1.30<0.001
Total cholesterol (mmol/L)4.86 ± 0.835.00 ± 0.834.81 ± 0.82<0.0014.93 ± 0.844.81 ± 0.820.006
HDL cholesterol (mmol/L)1.40 ± 0.331.32 ± 0.271.42 ± 0.34<0.0011.36 ± 0.301.42 ± 0.340.001
LDL cholesterol (mmol/L)2.81 ± 0.702.88 ± 0.682.79 ± 0.700.0322.83 ± 0.712.80 ± 0.690.552
Triglycerides (mmol/L)1.41 ± 0.811.63 ± 0.821.34 ± 0.79<0.0011.48 ± 0.761.37 ± 0.830.010
Systolic blood pressure (mmHg)127.36 ± 16.00131.57 ± 15.41125.87 ± 15.95<0.001128.58 ± 16.23126.65 ± 15.840.023
Diastolic blood pressure (mmHg)79.23 ± 9.7582.16 ± 9.4278.19 ± 9.65<0.00180.32 ± 10.1878.59 ± 9.43<0.001

3.2. Obesity Indices and Metabolic Syndrome Using ROC Curves

Table 3 and Figure 1 show gender specific area under ROC curve and optimal cut-off points with corresponding validity parameters for different obesity indices in predicting MetS. Among men, WC followed by both WHR and WHtR yielded the highest AUC (0.78; 95% CI 0.74–0.82 and 0.75; 95% CI 0.71–0.79, resp.). Unlike men, among women WC followed by WHtR yielded the highest area under the curve (0.81; 95% CI 0.78–0.85 and 0.79; 95% CI 0.76–0.83). BMI produced the lowest AUC in both men and women (0.56; 95% CI 0.51–0.61 and 0.70; 95% CI 0.66–0.74, resp.).

AUC (95% CI)Cut-off valueSensitivitySpecificityYouden index

 Body mass index (BMI)0.56 (0.51–0.61)28 kg/m258.0%52.9%0.109
30 kg/m238.5%66.7%0.052
 Waist circumference (WC)0.78 (0.74–0.82)99.5 cm81.6%63.9%0.455
102 cm75.9%67.3%0.432
 Waist height ratio (WHtR)0.74 (0.71–0.79)0.5875.1%64.8%0.399
 Waist hip ratio (WHR)0.75 (0.71–0.79)0.9070.1%69.9%0.400
 Body mass index (BMI)0.70 (0.66–0.74)28.4 kg/m273.7%64.8%0.385
30 kg/m266.4%67.1%0.335
 Waist circumference (WC)0.81 (0.78–0.85)91.0 cm86.5%64.7%0.512
88 cm94.4%53.2%0.476
 Waist height ratio (WHtR)0.79 (0.76–0.83)0.6377.6%71.5%0.491
 Waist hip ratio (WHR)0.75 (0.72–0.79)0.8875.4%71.5%0.469

AUC: area under the curve, ROC: receiver operating characteristics, CI: confidence interval.

Among men, WC at a cut-off value of 99.5 cm resulted in the highest Youden index with corresponding sensitivity of 81.6% and 63.9% specificity. At a traditional cut-off value of 102 cm of WC for men, the sensitivity dropped to 75.9%, and specificity slightly raised to 67.3%. Similarly among women, WC at a cut-off point of 91 cm resulted in highest Youden index with the corresponding sensitivity and specificity of 86.5% and 64.7%, respectively. At a traditional cut-off point of 88 cm WC among women, the sensitivity steeply increased to 94.4%, but this happened at the expense of significant drop in the specificity from 64.7% to 53.2%. Among both men and women, the BMI at a cut-off value of 28 kg/m2 and the traditional cut-off value of 30 kg/m2 were found to be having the lowest Youden index and corresponding sensitivity and specificity. WC at a cut-off point of 99.5 cm among men and 91 cm among women happened to be the best predictor of metabolic syndrome in Qatari population.

Figure 2 shows that adjusted odds ratios (OR) for metabolic syndrome for one quartile increase in anthropometric variables in Qatari population. All the models are adjusted for age, education, smoking status, and family history of hypertension and diabetes: (a) model for the general population, (b) model for female population, and (c) model for male population. The figure shows that the adjusted odds ratio of MetS is the highest for one quartile increase in the WC as compared to all the other indices of obesity irrespective of gender.

4. Discussion

In this cross-sectional survey of Qatari nationals aged 20 years and above, we found that the overall prevalence of MetS was 26% according to ATPIII and 37% according to IDF criteria which was consistent with the previous study conducted among Qatari adult population [2]. In addition, as per the main aim of this study we found that WC was a better predictor of MetS as compared to other obesity indices such as BMI, WHR, and WHtR in both men and women. The optimal cut-off values of WC to predict MetS were 99.5 cm and 91 cm in men and women, respectively. Those of WHR, WHtR, and BMI were 0.90 and 0.88, 0.58 and 0.63, 28 kg/m2 and 28.4 kg/m2 in men and women, respectively.

Which measure of obesity should be used for predicting MetS is widely debated. A recent cross-sectional survey among adult Iranian population found that WC was superior to BMI and WHR in discriminating MetS among healthy individuals [11]. Similarly, another cross-sectional survey among Whites and African American adult population in US reported WC to be the most powerful tool in predicting MetS and BMI was inferior to WC among men in general but not women [6]. However, a cross-sectional survey among Chinese adult population reported WC, WHR, and BMI as equally useful indicators to discriminate between those with and without MetS [14]. Among Cohort studies, the San Antonio Heart Study reported both BMI and WC as having equal power in predicting development of MetS in non-Hispanic Whites and Mexican Americans [15]. While on the other hand, a follow-up study among Korean adults found WHR as better predictor of multiple metabolic risk factors than WC, WHtR, and BMI [10]. On the contrary, an INTERHEART study among a large cohort of primary care patients reported WHtR as a better predictor of metabolic risk factors except hypertension as compared to other obesity indices, while interestingly BMI was found to be the better predictor of hypertension alone as compared to other obesity measurements [16]. These ethnic variations in results suggest that predictive power of each obesity index differ by ethnic group and therefore we believe that the discrete decision to select particular obesity index for diagnosis of MetS should be specific to each ethnic population. Based on this study, we found WC as a better predictor of MetS in both Qatari men and women. Our results are robust after adjusting for known confounders such as age, education, smoking, and family history of diabetes and hypertension using multivariable logistic regression.

Irrespective of all these ethnic variations regarding appropriateness of obesity indices, studies have shown that BMI poorly discriminates between excess adipose tissue and high lean muscle mass and that it does not account for body fat distribution [17, 18]. On the other hand, WC is reported to be better correlated with abdominal fat and strongly associated with cardiovascular risk factors than BMI [1921]. Therefore, WC is most commonly recommended to assess cardiovascular risk factors and is widely used in the definition of MetS [1, 12, 22]. Nevertheless, some researchers reported that measuring WC alone as a surrogate for abdominal fat distribution might overestimate the risk of MetS in tall subjects and underestimate in short subjects [23]. Therefore, they prefer WC adjusted for height as WHtR a better surrogate for measuring abdominal obesity [24, 25]. However, follow-up studies in Denmark and Japan did not support the importance of WC adjusted for height (WHtR) as a measure of adiposity in both men and women to identify metabolic risk factors [26, 27].

In this study we found that WC at a cut-off value of 99.5 cm for men and 91 cm for women has the highest sensitivity and specificity to predict the development of MetS. When we applied the WC cut-off value of 102 cm for men and 88 cm for women as recommended by ATPIII criteria [1], the sensitivity to discriminate between those with and without MetS dropped from 81.6% to 75.9% in men and the specificity dropped from 64.7% to 53.2% among women. A study among Iran adult population reported WC cut-off point of 90.3 cm among women which is similar to our findings, but their reported cut-off point for men was 90 cm which is lower than our cut-off for men [11]. Another study from Basra city in Iraq also reported slightly different WC cut-off value of 97 cm for men and 99 cm for women to diagnose MetS using the IDF criteria [28]. These minor differences in the cut-off values might be attributed to ethnic variations and using different criteria for diagnosing MetS. Nevertheless, similar to our finding all these studies show that cut-off points lower than currently recommended by ATPIII criteria for WC are needed for men while higher cut-off points are suggested for women to identify MetS among adult population in the region.

Our results also show that, after the WC, WHR at a cut-off point of 0.90 for men and 0.88 for women yields the highest sensitivity and specificity to differentiate MetS. This finding is consistent with previous studies from Oman, Korea, and Iran [8, 10, 11]. We found BMI to be the poorest predictor of MetS as compared to other obesity indices. Yet, at a slightly lower cut-off value of 28 kg/m2 than the recommended cut-off point by WHO [13] for both men and women it produced better sensitivity and specificity to predict the risk of MetS. Previous studies in Iran, Oman, and Korea also suggest using the lower cut-off points for BMI to better predict the development of MetS [11].

Our study has two important limitations. Firstly, the cross-sectional design of this study has inherent limitation of temporality and hence inability to draw causal inferences. Secondly, we could not adjust our sample size calculation for the potential nonresponse bias. However, despite these limitations we were able to recruit a large number of representative samples with a response rate of 71% from both rural and urban areas of Qatar and our results are generalizable to the entire Qatari adult population.

5. Conclusion

Waist circumference at a cut-off point of 99.5 cm among men and 91 cm among women happened to be the best predictor of metabolic syndrome in Qatari population. Using the traditional cut-off values of 102 cm for men and 88 cm in women as recommended by ATPIII criteria for the Arab region might result in underestimation of MetS among men and overestimation among women. Looking at the discrepancies we recommend that WHO, IDF, and ATPIII criteria for obesity might not be appropriate for predicting the risk of MetS among Qatari adult population.


The project was supported and funded by the Diabetic Association, Qatar Foundation and Hamad Medical Corporation. The authors also, would like to thank Hamad Medical Corporation IRB Committee for their approval on this study (HMC Research Protocol no. 10262-1027A/2011).


  1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), “Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report,” Circulation, vol. 106, pp. 3143–3421, 2002. View at: Google Scholar
  2. A. Bener, A.-G. Mohammad, A. N. Ismail, M. Zirie, W. K. Abdullatef, and A. O. A. A. Al-Hamaq, “Gender and age-related differences in patients with the metabolic syndrome in a highly endogamous population,” Bosnian Journal of Basic Medical Sciences, vol. 10, no. 3, pp. 210–217, 2010. View at: Google Scholar
  3. C. L. Scott, “Diagnosis, prevention and intervention for the metabolic syndrome,” American Journal of Cardiology, vol. 92, pp. 35i–42i, 2003. View at: Google Scholar
  4. D. E. Moller and K. D. Kaufman, “Metabolic syndrome: a clinical and molecular perspective,” Annual Review of Medicine, vol. 56, pp. 45–62, 2005. View at: Publisher Site | Google Scholar
  5. Y.-W. Park, S. Zhu, L. Palaniappan, S. Heshka, M. R. Carnethon, and S. B. Heymsfield, “The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994,” Archives of Internal Medicine, vol. 163, no. 4, pp. 427–436, 2003. View at: Publisher Site | Google Scholar
  6. M. A. Beydoun, M. T. Fanelli Kuczmarski, Y. Wang, M. A. Mason, M. K. Evans, and A. B. Zonderman, “Receiver-operating characteristics of adiposity for metabolic syndrome: the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) study,” Public Health Nutrition, vol. 14, no. 1, pp. 77–92, 2011. View at: Publisher Site | Google Scholar
  7. M. Takahashi, K. Shimomura, P. Proks et al., “A proposal of combined evaluation of waist circumference and BMI for the diagnosis of metabolic syndrome,” Endocrine Journal, vol. 56, no. 9, pp. 1079–1082, 2009. View at: Publisher Site | Google Scholar
  8. J. A. Al-Lawati and P. Jousilahti, “Body mass index, waist circumference and waist-to-hip ratio cut-off points for categorisation of obesity among Omani Arabs,” Public Health Nutrition, vol. 11, no. 1, pp. 102–108, 2008. View at: Publisher Site | Google Scholar
  9. S.-H. Park, S.-J. Choi, K.-S. Lee, and H.-Y. Park, “Waist circumference and waist-to-height ratio as predictors of cardiovascular disease risk in Korean adults,” Circulation Journal, vol. 73, no. 9, pp. 1643–1650, 2009. View at: Publisher Site | Google Scholar
  10. K. P. Ko, D. K. Oh, H. Min et al., “Prospective study of optimal obesity index cutoffs for predicting development of multiple metabolic risk factors: the korean genome and epidemiology Study,” Journal of Epidemiology, vol. 22, pp. 433–439, 2012. View at: Google Scholar
  11. M. Gharipour, N. Sarrafzadegan, M. Sadeghi et al., “Predictors of metabolic syndrome in the iranian population: waist circumference, body mass index, or waist to hip ratio?” Cholestrol, vol. 2013, Article ID 198384, 6 pages, 2013. View at: Publisher Site | Google Scholar
  12. K. G. M. M. Alberti and P. Zimmet, “Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation,” Diabetic Medicine, vol. 23, no. 5, pp. 469–480, 2006. View at: Publisher Site | Google Scholar
  13. WHO, Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity, WHO, Geneva, Switzerland, 1997.
  14. Y. Liu, G. Tong, W. Tong, L. Lu, and X. Qin, “Can body mass index, waist circumference, waist-hip ratio and waist-height ratio predict the presence of multiple metabolic risk factors in Chinese subjects?” BMC Public Health, vol. 11, article 35, 2011. View at: Publisher Site | Google Scholar
  15. T. S. Han, K. Williams, N. Sattar, K. J. Hunt, M. E. J. Lean, and S. M. Haffner, “Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: san Antonio Heart Study,” Obesity Research, vol. 10, no. 9, pp. 923–931, 2002. View at: Google Scholar
  16. H. J. Schneider, J. Klotsche, G. K. Stalla, and H.-U. Wittchen, “Obesity and risk of myocardial infarction: the INTERHEART Study,” The Lancet, vol. 367, no. 9516, p. 1052, 2006. View at: Publisher Site | Google Scholar
  17. A. Romero-Corral, V. M. Montori, V. K. Somers et al., “Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies,” The Lancet, vol. 368, no. 9536, pp. 666–678, 2006. View at: Publisher Site | Google Scholar
  18. D. C. Frankenfield, W. A. Rowe, R. N. Cooney, J. S. Smith, and D. Becker, “Limits of body mass index to detect obesity and predict body composition,” Nutrition, vol. 17, no. 1, pp. 26–30, 2001. View at: Publisher Site | Google Scholar
  19. S. M. Grundy, I. J. Neeland, A. T. Turer, and G. L. Vega, “Waist circumference as measure of abdominal fat compartments,” Journal of Obesity, vol. 2013, Article ID 454285, 9 pages, 2013. View at: Publisher Site | Google Scholar
  20. S. Zhu, S. B. Heymsfield, H. Toyoshima, Z. Wang, A. Pietrobelli, and S. Heshka, “Race-ethnicity-specific waist circumference cutoffs for identifying cardiovascular disease risk factors,” American Journal of Clinical Nutrition, vol. 81, no. 2, pp. 409–415, 2005. View at: Google Scholar
  21. G. N. Thomas, S.-Y. Ho, K. S. L. Lam, E. D. Janus, A. J. Hedley, and H. L. Tai, “Impact of obesity and body fat distribution on cardiovascular risk factors in Hong Kong Chinese,” Obesity Research, vol. 12, no. 11, pp. 1805–1813, 2004. View at: Google Scholar
  22. S. M. Grundy, J. I. Cleeman, S. R. Daniels et al., “Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement,” Circulation, vol. 112, no. 17, pp. 2735–2752, 2005. View at: Publisher Site | Google Scholar
  23. S. D. Hsieh and H. Yoshinaga, “Do people with similar waist circumference share similar health risks irrespective of height?” Tohoku Journal of Experimental Medicine, vol. 188, no. 1, pp. 55–60, 1999. View at: Google Scholar
  24. M. Ashwell and S. Gibson, “Waist to height ratio is a simple and effective obesity screening tool for cardiovascular risk factors: analysis of data from the british national diet and nutrition survey of adults aged 19–64 years,” Obesity Facts, vol. 2, no. 2, pp. 97–103, 2009. View at: Publisher Site | Google Scholar
  25. S. D. Hsieh, M. Ashwell, T. Muto, H. Tsuji, Y. Arase, and T. Murase, “Urgency of reassessment of role of obesity indices for metabolic risks,” Metabolism, vol. 59, no. 6, pp. 834–840, 2010. View at: Publisher Site | Google Scholar
  26. K. Nakamura, H. Nanri, M. Hara et al., “Optimal cutoff values of waist circumference and the discriminatory performance of other anthropometric indices to detect the clustering of cardiovascular risk factors for metabolic syndrome in Japanese men and women,” Environmental Health and Preventive Medicine, vol. 16, no. 1, pp. 52–60, 2011. View at: Publisher Site | Google Scholar
  27. T. S. Han, G. McNeill, J. C. Seidell, and M. E. J. Lean, “Predicting intra-abdominal fatness from anthropometric measures: the influence of stature,” International Journal of Obesity, vol. 21, no. 7, pp. 587–593, 1997. View at: Google Scholar
  28. A. A. Mansour, A. A. Al-Hassan, and M. I. Al-Jazairi, “Toward establishing normal waist circumference in Eastern Mediterranean and Middle East (Arab) populations. Cutoff values for waist circumference in Iraqi adults,” International Journal of Diabetes and Metabolism, vol. 15, no. 1, pp. 14–16, 2007. View at: Google Scholar

Copyright © 2013 Abdulbari Bener et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.